Literature DB >> 24352253

A case of refractory Sézary syndrome with large-cell transformation responsive to brentuximab vedotin.

Kristen Corey1, Deborah Cook2, Jessica Bekker2, Emiliano Mugnaini3, Julie H Lin4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24352253     DOI： 10.1001/jamadermatol.2013.5741

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  3 in total

1.  CD30 Expression Is Rare in Myeloid Leukemia Cutis: A Study of 55 Cases and Implications for Routine Diagnostic Algorithms.

Authors:  Olakunle Ogunrinade; David Terrano; April Chiu; Melissa Pulitzer
Journal:  Am J Dermatopathol       Date:  2017-05       Impact factor: 1.533

Review 2.  Cutaneous T cell Lymphoma: an Update on Pathogenesis and Systemic Therapy.

Authors:  Catherine G Chung; Brian Poligone
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

Review 3.  Targets, Toxins, and T Cells--a Review of New Monoclonal Antibodies in the Treatment of Peripheral T Cell Lymphomas.

Authors:  Jonathan Hebb; Holbrook Kohrt
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 4.213
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.